NovaBay Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
NovaBay Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2011 to Q3 2022.
  • NovaBay Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
  • NovaBay Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • NovaBay Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
  • NovaBay Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $5K, a 16.7% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 -$1K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1K -$1K -50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q2 2019 $2K +$1K +100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q2 2018 $1K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2017 $1K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q2 2016 $2K -$4K -66.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q4 2015 $2K -$8K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 $2K +$2K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $6K -$4K -40% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $2K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $0 -$3K -100% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $10K +$3K +42.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q4 2013 $1.6K -$10.4K +$5.6K +35% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 -$4K $3K -$3K -50% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$1K $7K +$1K +16.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$2K $2K -$4K -66.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $2K -$16K +$3K +15.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-26
Q3 2012 -$1K $6K +$1K +20% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2K $6K +$2K +50% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 -$4K $6K -$6K -50% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $2K -$19K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-06
Q3 2011 $5K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $4K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $12K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.